Figure 1: Western blot analysis using VIL1 mAb against human VIL1 (AA: 1-209) recombinant protein. (Expected MW is 49.4 kDa)
Figure 2: Western blot analysis using VIL1 mAb against HEK293 (1) and VIL1 (AA: 1-209)-hIgGFc transfected HEK293 (2) cell lysate.
Figure 3: Western blot analysis using VIL1 mouse mAb against SW620 cell lysate.
Figure 4:Immunofluorescence analysis of Hela cells using VIL1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Figure 5: Flow cytometric analysis of SW620 cells using VIL1 mouse mAb (green) and negative control (red).
Figure 6: Immunohistochemical analysis of paraffin-embedded cervical cancer tissues using VIL1 mouse mAb with DAB staining.
Black line: Control Antigen (100 ng); Purple line: Antigen(10ng); Blue line: Antigen (50 ng); Red line: Antigen (100 ng);